Further studies are needed to corroborate our results on the role of TWIST1 in EMT in ESCC including complementary assays to display TWIST1-medaiated regulation of CSC markers through binding to their E-boxes as well as further immunostaining assays for CSC markers to confirm our ICC and flow cytometry results. Here, TWIST1 is linked to esophageal squamous cell carcinoma.